Literature DB >> 27132414

Correlation of the system of cytokines in moderate and severe preeclampsia.

A Markova Daneva, M Hadži-Lega, M Stefanovic.   

Abstract

OBJECTIVE OF THE STUDY: To study the production of pro-inflammatory (IL-1β, IL- 2, IL-6, IL-8) and anti-inflammatory (IL-4, IL-10) cytokines in pregnancy complicated by preeclampsia in the third trimester. Institution: University Clinic of Gynecology and Obstetrics, Skopje, Republic of Macedonia.
MATERIAL AND METHODS: Fifty women with pregnancies complicated by preeclampsia in the third trimester and 50 women with physiological pregnancy. Levels of IL-1β, IL-2, IL-6, IL-8, IL-4, and IL-10 were measured by using a solid-phase enzyme immunoassay. Statistical data processing was done using the application program SPSS for Windows 13.0. To describe the distribution of analyzed variables, descriptive methods (mean, median, minim and max) were used .
RESULTS: In pregnancies complicated by preeclampsia, there are increased levels of proinflammatory cytokines and a change in the behaviour of opposing pools. Most pronounced changes in the levels of proinflammatory cytokines were observed in mild preeclampsia. In severe preeclampsia there was reduction of the concentration of anti-inflammatory cytokines IL-4 and IL-10.
CONCLUSION: The use of assessment cytokine profile monitoring of health status of women with preeclampsia is expedient.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27132414

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  8 in total

Review 1.  Biosensors for Detection of Human Placental Pathologies: A Review of Emerging Technologies and Current Trends.

Authors:  Jia Liu; Babak Mosavati; Andrew V Oleinikov; E Du
Journal:  Transl Res       Date:  2019-05-20       Impact factor: 7.012

2.  Maternal cytokine status may prime the metabolic profile and increase risk of obesity in children.

Authors:  B Englich; G Herberth; U Rolle-Kampczyk; S Trump; S Röder; M Borte; G I Stangl; M von Bergen; I Lehmann; K M Junge
Journal:  Int J Obes (Lond)       Date:  2017-05-10       Impact factor: 5.095

3.  Postpartum increases in cerebral edema and inflammation in response to placental ischemia during pregnancy.

Authors:  Ahsia M Clayton; Qingmei Shao; Nina D Paauw; Ashtin B Giambrone; Joey P Granger; Junie P Warrington
Journal:  Brain Behav Immun       Date:  2018-03-26       Impact factor: 7.217

4.  Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis: Systematic Review and Meta-Analysis.

Authors:  Meryl C Nath; Hajrunisa Cubro; Daniel J McCormick; Natasa M Milic; Vesna D Garovic
Journal:  Hypertension       Date:  2020-10-26       Impact factor: 10.190

Review 5.  Medawar's PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation.

Authors:  Ellen Menkhorst; Nandor Gabor Than; Udo Jeschke; Gabriela Barrientos; Laszlo Szereday; Gabriela Dveksler; Sandra M Blois
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

Review 6.  Nonlinear analysis of heart rhythm in preeclampsia: a route for translational clinical applications in neuroinflammation.

Authors:  José Javier Reyes-Lagos; Eric Alonso Abarca-Castro
Journal:  Clin Hypertens       Date:  2021-12-15

7.  Chronic Venous Disease during Pregnancy Causes a Systematic Increase in Maternal and Fetal Proinflammatory Markers.

Authors:  Miguel A Ortega; Ana M Gómez-Lahoz; Lara Sánchez-Trujillo; Oscar Fraile-Martinez; Cielo García-Montero; Luis G Guijarro; Coral Bravo; Juan A De Leon-Luis; Jose V Saz; Julia Bujan; Natalio García-Honduvilla; Jorge Monserrat; Melchor Alvarez-Mon
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

8.  Association of pro- and anti-inflammatory cytokines in preeclampsia.

Authors:  Ruby Aggarwal; Arun Kumar Jain; Pratima Mittal; Mangala Kohli; Poonam Jawanjal; Gayatri Rath
Journal:  J Clin Lab Anal       Date:  2019-01-21       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.